Where is House Rx located?

House Rx is headquartered in San Francisco, United States.

Who is the current CEO of House Rx?

Ogi Kavazovic of House Rx. They have also founded 1 company.

How many employees does House Rx have?

As of Sep 30, 2026, the latest employee count at House Rx is 293.

Is House Rx a funded company?

House Rx is a funded company, having raised a total of $100M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round.

When was the latest funding round of House Rx?

House Rx's latest funding was a $***** Conventional Debt round on Nov 12, 2025, with participation from 6 investors.

Where does House Rx rank among its competitors?

House Rx ranks 1st amongst 45 active competitors, of which 7 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was House Rx, which secured $55M in Nov, 2025.

Who are the top competitors of House Rx?

House Rx's top competitors include GalenusRx, Eurekam and DecisionRx. Among them, House Rx secured the most recent funding round in November, 2025.

House Rx - 2026 Company Profile, Team, Funding & Competitors

House Rx is a series B company based in San Francisco (United States), founded in 2005 by Ogi Kavazovic. It operates as a Provider of a technology-based medication solution for patients and caregivers. House Rx has raised $100M in funding from investors like First Round Capital, Bessemer Venture Partners and New Enterprise Associates. The company has 45 active competitors, including 7 funded and 1 that has exited. Its top competitors include companies like GalenusRx, Eurekam and DecisionRx.

Company Details

Provider of a technology-based medication solution for patients and caregivers. It is focused on transforming the specialty pharmacy experience for both patients and providers. Their core mission is to remove barriers to specialty medication access, improve patient outcomes, and streamline the medication process.

Website: www.houserx.com/
Email ID: *****@houserx.com

Key Metrics

Founded Year

2005

Location

San Francisco, United States

Stage

Series B

Total Funding

$100M in 5 rounds

Latest Funding Round

Conventional Debt, Nov 12, 2025, $*****

Investors

First Round Capital & 10 more

Ranked

1^st among 45 active competitors

Employee Count

293 as on Sep 30, 2026

Similar Companies

GalenusRx & 50 more

View House Rx's full profile

House Rx has raised a total funding of $100M over 5 rounds. Its latest funding round was a Conventional Debt round on Nov 12, 2025 for $*****. 6 investors participated in its latest round. House Rx has 11 institutional investors.

Here is the list of recent funding rounds of House Rx:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 12, 2025	6779877	Conventional Debt	8343551	9626071	6793941	8563133
Nov 12, 2025	6602065	Series B	8081947	2685766	7656136	Town Hall Ventures & 4 more
Jun 07, 2024	7462028	Series A	8568183	4700515	4928896	7918053

Access funding benchmarks and valuations. Sign up today!

View details of House Rx's funding rounds and investors

The founders of House Rx is Ogi Kavazovic. Ogi Kavazovic is the CEO of House Rx.

Here are the details of House Rx's key team members:

Ogi Kavazovic: Co-Founder & CEO of House Rx.
Contact Info: 1 email address

View details of House Rx's Founder profiles and Board Members

House Rx's employee count trend

House Rx has 293 employees as of Sep 26. Here is House Rx's employee count trend over the years:

Uncover House Rx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of House Rx include GalenusRx, Eurekam and DecisionRx. Here is the list of Top 10 competitors of House Rx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	House Rx 2005, San Francisco (United States), Series B	Provider of a technology-based medication solution for patients and caregivers	$100M	Maverick Ventures, First Round Capital & 9 others	65/100
2nd	GalenusRx 2023, Fernandina Beach (United States), Series A	Provider of medication safety risk management solution for healthcare organization	$6.88M	-	48/100
3rd	Eurekam 2012, Lagord (France), Series B	Provider of medication management solutions for oncology professionals	$8.84M	Sofimac Investment Managers, SWEN Capital Partners ... & 4 others	40/100
4th	DecisionRx 2022, Indianapolis (United States), Funding Raised	Provider of medication management solutions to patients and healthcare providers	-	Health Cloud Capital, The Carlyle Group & 1 others	33/100
5th	Surveyor Health 2009, San Mateo (United States), Seed	Provider of medication management solutions for healthcare organisations	$98K	-	32/100
6th	Pillcheck 2013, Vaughan (Canada), Funding Raised	Provider of DNA testing platform to identify medication response of users	-	Ontario Centre of Innovation	31/100
7th	Mistura Informatics 2011, Ashington (United Kingdom), Unfunded	Provider of medication management and electronic resources software for pharmacists, and healthcare professionals	-	-	26/100
8th	SHAARPEC 2019, Stockholm (Sweden), Unfunded	Provider of a healthcare analytics platform for healthcare organizations	-	-	26/100
9th	Prescription Advisory Systems & Technology 2013, Jenkintown (United States), Seed	Intelligent PDMP review, saving time and improving clinical decision-making	$2.37M	Ben Franklin Technology Partners	26/100
10th	PGXperts 2013, Furth (Germany), Unfunded	Digital medication management and therapy planning tool for healthcare providers	-	-	25/100